20Feb 2025
Long-Term Efficacy of Ritlecitinib in Alopecia Areata Treatment

Long-Term Efficacy of Ritlecitinib in Alopecia Areata Treatment

The post hoc analysis of the ALLEGRO-LT study assessed long-term response patterns to ritlecitinib in alopecia areata patients. Among 191 participants, 45% achieved a sustained response (SALT ≤20), with 46% reaching complete response. Female sex, shorter disease duration, and less extensive hair loss correlated with better outcomes. Findings suggest extended treatment duration may be necessary for optimal efficacy.

  • #dermatology

Like

Save

Share